The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
A prospective study of acute drug‐induced liver injury in patients suffering from non‐alcoholic fatty liver disease
Abstract
Aim: Liver damage due to facultative hepatotoxins is scarcely foreseeable. We evaluated the prevalence of acute drug‐induced liver injury (DILI) in a specific setting, assessing eventual interactions with pre‐existing hepatic illnesses. Methods: The research was carried out in an Italian tertiary care hospital, by analyzing 248 patients with non‐advanced liver disease, divided into two well‐matched groups: 174 patients (median age 53, 94 females) with hepatitis C virus‐related chronic hepatitis; and 74 (median age 55, 39 females) with non‐alcoholic fatty liver disease (NAFLD). Results: Six patients (2.4% of the whole population) belonging to the NAFLD group (χ2‐test, P = 0.004) suffered from acute hepatoxicity related to the following drugs, that is antihypertensive, acting on platelet aggregation, antimicrobial, non‐steroidal anti‐inflammatory and proton pump inhibitor. The NAFLD presence was an independent risk factor in determining drug‐related acute hepatitis, with an odds ratio of 3.95 (95% confidence intervals: 11.48–1.35). Central obesity was relevant in every patient with acute toxicity. Alcohol consumption and drug association did not influence the acute drug‐induced liver damage. Conclusion: NAFLD conveys a nearly fourfold increase of DILI risk in obese middle‐aged patients. NAFLD, characterized by mitochondrial dysfunction, could predispose to drug‐induced hepatotoxicity that probably shares the same pathophysiological mechanism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Some small-sample-size studies suggest that NAFLD may increase the risk of all-cause DILI.
“Similarly, some small-sample-size studies suggest that NAFLD may increase the risk of all-cause DILI [101][102][103].”
From Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update (2024) · cites this paper as [103]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2022) · doi:10.1176/appi.books.9780890425787 · Cited by 23,476
Mitochondrial dysfunction in Nash: causes, consequences and possible means to prevent it
Begriche, K., Igoudjil, A., Pessayre, D., & Fromenty, B. (2006) · Mitochondrion · doi:10.1016/j.mito.2005.10.004 · Cited by 753
Flagged first, then by citations
Research works printed but not linked: 25
- 10.1073/pnas.84.2.551 · DOI
- 10.1016/0168-8278(95)80226-6 · DOI
- 10.1002/hep.20701 · DOI · Paper page
- 10.2165/00002018-200225060-00012 · DOI
- 10.1176/ajp.127.12.1653 · DOI
- 10.1093/alcalc/agg051 · DOI
- 10.1016/j.numecd.2004.09.002 · DOI
- 10.2337/diacare.29.02.06.dc05-1885 · DOI
- 10.1016/S0168-8278(01)00098-8 · DOI
- 10.1001/jama.1997.03550190036037 · DOI
- Berg P, 2001, Hepatotoxic reactions induced by beta‐lactamase inhibitors., Eur J Med Res, 6, 535
- 10.1345/aph.1A406 · DOI
- 10.7326/0003-4819-144-6-200503210-00121 · DOI
- 10.1097/01.pec.0000173350.45648.9b · DOI
- 10.1002/(SICI)1099-1557(199808)7:1 <S41::AID-PDS347>3.0.CO;2-2 · DOI
- 10.1002/hep.510270121 · DOI
- 10.2165/00003088-200038060-00003 · DOI
- 10.1016/j.tiv.2006.01.021 · DOI · Paper page
- Ong MM, 2006, Troglitazone‐induced hepatic necrosis in an animal model of silent genetic mitochondrial abnormalities., Toxicol Sci, 00, 000
- 10.1002/1098-2280(2001)37:1<46::AID-EM1005>3.0.CO;2-6 · DOI
- 10.2174/1389200043335531 · DOI
- 10.1080/01926230590522121 · DOI
- 10.1053/jhep.2000.9034 · DOI
- 10.1023/A:1007649815992 · DOI
- 10.1097/00000542-198208000-00005 · DOI
Cited by
Sorted by citations
Risk Factors for Idiosyncratic Drug-Induced Liver Injury
Chalasani, N., & Björnsson, E. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.001 · Cited by 347
Labbe, G., Pessayre, D., & Fromenty, B. (2008) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00608.x · Cited by 317
Central role of mitochondria in drug-induced liver injury
Pessayre, D., Fromenty, B., Berson, A., Robin, M.-A., Lettéron, P., Moreau, R., & Mansouri, A. (2012) · Drug Metabolism Reviews · doi:10.3109/03602532.2011.604086 · Cited by 277
Idiosyncratic drug-induced liver injury: an overview
Hussaini, S. H., & Farrington, E. A. (2007) · Expert Opinion on Drug Safety · doi:10.1517/14740338.6.6.673 · Cited by 183
Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines
Devarbhavi, H., Aithal, G., Treeprasertsuk, S., Takikawa, H., Mao, Y., Shasthry, S. M., Hamid, S., Tan, S. S., Philips, C. A., George, J., et al. (2021) · Hepatology International · doi:10.1007/s12072-021-10144-3 · Cited by 181
Mitochondrial adaptation in steatotic mice
Einer, C., Hohenester, S., Wimmer, R., Wottke, L., Artmann, R., Schulz, S., Gosmann, C., Simmons, A., Leitzinger, C., Eberhagen, C., et al. (2018) · Mitochondrion · doi:10.1016/j.mito.2017.08.015 · Cited by 72
Loss of autophagy promotes murine acetaminophen hepatotoxicity
Igusa, Y., Yamashina, S., Izumi, K., Inami, Y., Fukada, H., Komatsu, M., Tanaka, K., Ikejima, K., & Watanabe, S. (2012) · Journal of Gastroenterology · doi:10.1007/s00535-011-0500-0 · Cited by 66
Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update
Mao, Y., Ma, S., Liu, C., Liu, X., Su, M., Li, D., Li, Y., Chen, G., Chen, J., Chen, J., et al. (2024) · Hepatology International · doi:10.1007/s12072-023-10633-7 · Cited by 62
Mechanisms of idiosyncratic drug-induced liver injury
Uetrecht, J. (2019) · Advances in pharmacology · doi:10.1016/bs.apha.2018.12.001 · Cited by 49
Metadata
- Authors
- Tarantino, G., Conca, P., Basile, V., Gentile, A., Capone, D., Polichetti, G., & Leo, E.
- Venue
- Hepatology Research
- Publisher
- Wiley
- Published
- 2007-05-26
- Volume
- 37
- Issue
- 6
- Pages
- 410-415
- ISSN
- 1386-6346
- 1872-034X
- Cited by
- 145
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review